Moderators: QuantumTravesty
Search This Board: 
Created: 01/25/2013 01:09:32 PM - Followers: 49 - Board type: Free - Posts Today: 0
Kintara Therapeutics is focused on developing unique anti-cancer compounds, supported by a strong scientific rationale for development in indications with established biomarkers, and where patients are failing, or are unable to tolerate, current therapies.

           VAL-083 Shows Potential Against Multiple Cancers 

VAL-083 is a "first-in-class" small molecule chemotherapeutic. Its unique structure provides many valuable benefits, including the targeting of DNA for its therapeutic effect and its ability to cross the blood brain barrier, critical for activity against central nervous system (CNS) tumors.

VAL-083 has completed Pre-Clinical, Phase I and II trials for the treatment of bevacizumab-refractory glioblastoma multiforme (GBM) and is currently being studied in two Phase II biomarker-driven clinical trials for unmethylated-MGMT GBM.

We are also pursuing the development of VAL-083 in the treatment of ovarian cancer.


REM-001 is a Proprietary Late Stage Photodynamic Therapy (“PDT”) Platform 

REM-001 has broad utility for the treatment of serious cutaneous oncology indications. REM-001 has been previously studied in four Phase 2 and/or Phase 3 clinical trials in patients with cutaneous metastatic breast cancer (“CMBC”), who had previously received chemotherapy and/or failed radiation therapy.

Zacks Small-Cap Research
Based on our DCF model and a 15% discount rate, Kintara Therapeutics is valued at approximately $5.25 per share. Our model applies a 60% probability for VAL-083 in unmethylated GBM, a 50% probability in methylated GBM and a 50% probability of approval and commercialization in REM-001 for CMBC. The model includes contributions from the United States and Europe. Other regions will be included upon further clarity.
Shares Outstanding (mil) 43.2
Current Price (10/8/2021) $0.77
Valuation $5.25.   


Thanks to its promising pipeline and $0.88 share price, 5-star analyst Michael King, of
H.C. Wainwright, sees an attractive entry point for investors.

“We are bullish about KTRA shares for the following five reasons
: (1) The GBM AGILE trial tests VAL-083 in
all three subtypes of GBM, allowing for multiple opportunities for VAL-083 to prove its
efficacy against phenotypically distinct types of the disease.
(2) VAL-083 is a bifunctional
alkylating agent that crosses the blood brain barrier and exhibits very favorable pharmacologic
properties relative TMZ; fulfilling the need for systemic availability in the brain.
(3) VAL-083
has an established favorable safety record, both from initial trials and prior clinical use in
multiple indications.
(4) Dire unmet need in GBM may present relatively low bar for approval.
(5) Phase 3 ready REM-001 is an additional bonus which is not factored into our valuation
assumptions and could potentially deliver value to shareholders while providing a backstop
against downside,” King explained.

PlusOneCoin Top Posts Free PlusOneCoin
No plusone'd posts yet. Be the first!
Post Subject
Did someone on this board say that kintara Maknmoney78 09/07/2022 01:54:58 PM
So far no! Only lower lows. Looks like QuantumTravesty 09/06/2022 03:58:16 PM
Are we sure this stock actually has a blackcat 09/06/2022 03:20:41 PM
rsi 30.89 @ $0.141 is either a bounce QuantumTravesty 09/06/2022 02:31:42 PM
Lol yes I think you’re right. QuantumTravesty 09/01/2022 04:38:41 PM
Whoever coined the phrase "slow train wreck" surely blackcat 09/01/2022 01:01:19 PM
Looking for a break of rsi 30 and QuantumTravesty 09/01/2022 12:16:49 PM
#1128 Maknmoney78 08/29/2022 11:41:55 AM
Anyone else loaded up more of these .15s Maknmoney78 08/24/2022 03:55:38 PM
My PCP thinks the CDC is looking at blackcat 08/18/2022 06:17:52 PM
Yeah that’s a bit of what I’ve been QuantumTravesty 08/18/2022 04:05:19 PM
We've all been planning trips "by booster shots". blackcat 08/18/2022 11:17:37 AM
Yes on all of that! All I have QuantumTravesty 08/18/2022 10:33:09 AM
Using a phone for trades can be hazardous! blackcat 08/18/2022 09:57:33 AM
That’s good. That’s what I was trying to QuantumTravesty 08/18/2022 09:44:35 AM
Haven't bought back. Just waiting................. blackcat 08/17/2022 02:33:18 PM
Well $0.18 is the new $0.20 QuantumTravesty 08/17/2022 10:58:54 AM
Par for their course............... blackcat 08/09/2022 10:44:45 AM
Who’s surprised here? QuantumTravesty 08/09/2022 10:20:13 AM
Well- I don't think it will hold- today, blackcat 08/05/2022 02:34:58 PM
So do you think it will hold here antman 08/05/2022 01:45:34 PM
Ugly! I knew they were bad, but didn't blackcat 08/04/2022 12:55:42 PM
Yes and yet it could have some pumps QuantumTravesty 08/04/2022 12:31:09 PM
We watched too many times. Toxic financing is blackcat 08/04/2022 12:11:00 PM
Yup because they’ve now hit the bottom of QuantumTravesty 08/04/2022 11:55:51 AM
They would be better off to just let blackcat 08/04/2022 11:30:44 AM
I’m going to try not to rush in QuantumTravesty 08/04/2022 10:28:28 AM
Got the 8KSpy Alert on $KTRA .....Boom........... Zardiw 08/04/2022 08:39:53 AM
That’s a negative ghost rider the pattern is QuantumTravesty 08/03/2022 02:04:46 PM
I have a hole in my head buying antman 08/03/2022 01:38:12 PM
Oh yes. I'm looking for support at .20 blackcat 08/03/2022 12:06:16 PM
Chart says they’ll try to hold support at QuantumTravesty 08/03/2022 11:26:46 AM
Good job averaging down and going to the QuantumTravesty 08/03/2022 11:23:01 AM
Sells completed at $.30. Not a big blackcat 08/03/2022 11:00:06 AM
Ding ding ding! If that’s your situation. QuantumTravesty 08/03/2022 10:37:45 AM
The usual. we issued 1,630,191 Commitment Shares QuantumTravesty 08/03/2022 10:35:03 AM
#1099 PENNIEStoSTACKS 08/03/2022 10:25:41 AM
Well- I have been just riding it. However- blackcat 08/03/2022 10:25:02 AM
In a case where it’s significantly upside down QuantumTravesty 08/03/2022 10:19:03 AM
Totally agree, That's why my comment was "I blackcat 08/03/2022 10:05:26 AM
Funny I missed the open and $0.40 with QuantumTravesty 08/03/2022 09:46:15 AM
Whew let’s hope that were true. Let me QuantumTravesty 08/03/2022 09:40:21 AM
KTRA doubled but isn't it just fancy words swampboots 08/03/2022 09:25:12 AM
I guess this counts as an upside catalyst......... blackcat 08/03/2022 09:05:04 AM
Kintara Therapeutics Enters Into Equity Purchase Agreement for subslover 08/03/2022 08:44:20 AM
Thanks , anyone expecting some substantial changes in ADVFN_abullman 07/31/2022 11:48:20 PM
Maybe I could just pretend I don't own any......... blackcat 07/27/2022 05:13:28 PM
RSI 30 oversold is like a lunar gravitational QuantumTravesty 07/27/2022 12:37:49 PM
Lol well yes and no. After putting in QuantumTravesty 07/26/2022 12:52:37 AM
What a surprise, yes? blackcat 07/25/2022 01:12:08 PM
Post Subject